We are live on !
Find out more
Enveric Biosciences
ENVB
ENVB
hedge funds and large institutions have $81.3K invested in Enveric Biosciences in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.73% less ownership
Funds ownership: 1.24% → 0.51% (-0.73%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $74K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$42K |
| 2 |
Renaissance Technologies
New York
|
-$12K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5K |
| 5 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$2K |